Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Vect-Horus

Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders
From Vect-Horus
Via GlobeNewswire
Vect-Horus appoints Philippe Masset to Board of Directors, in further strengthening of leadership
From Vect-Horus
Via GlobeNewswire
Vect-Horus appoints Carole Imbert as Chief Financial Officer to further reinforce its executive management team
From Vect-Horus
Via GlobeNewswire
Vect-Horus further strengthens leadership with appointment of strategy and finance executive Jérôme Berger to its Board of Directors
From Vect-Horus
Via GlobeNewswire
Vect-Horus Strengthens Board of Directors with Appointment of Jean-Christophe Dantonel as New Member
From Vect-Horus
Via GlobeNewswire
Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
From Vect-Horus
Via GlobeNewswire
Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to Organs and Tumors
From Vect-Horus
Via GlobeNewswire
Vect-Horus Enters Exclusive License Agreement with Ionis Pharmaceuticals to Advance Systemic Delivery of RNA-Targeted Medicines for Neurological Diseases
From Vect-Horus
Via Business Wire
Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Pr. Xavier Declèves
From Vect-Horus
Via Business Wire
Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
From Vect-Horus
Via Business Wire
Vect-Horus Appoints Dr Jean-Manuel Péan as Chief Scientific Officer
From Vect-Horus
Via Business Wire
Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Frédéric Matonti, a Leading Ophthalmology Specialist
From Vect-Horus
Via Business Wire
Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Dr. Julia Alterman
From Vect-Horus
Via Business Wire
Vect-Horus and RadioMedix Announce FDA Approval of Exploratory IND of Diagnostic 68 Ga-RMX-VH in Glioblastoma Multiforme
From Vect-Horus
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.